6Hopkins PM.Malignant hyperthermia:advances in clinical management and diagnosis.Br J Anaesth,2000,85:118-128.
7Islander G,Twetman ER.Comparison between the European and North American protocols for diagnosis of malignant hyperthermia susceptibility in humans.Anesth Analg,1999,88:1155-1160.
8Bendahan D,Guis S,Monnier N,et al.Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine:a comparative investigation in malignant hyperthermia.Acta Anaesthesiol Scand,2004,8:1019-1027.
9Bendahan D,Kozak Ribbens G,Rodet L,et al.31 Phosphorus magnetic resonance spectroscopy characterization of musclular metabolic anomalies in patients with malignant hyperthermia:application to diagnosis.Anesthesiology,1998,88:96-107.
10Rosenbe rg H,Antognini JF,Muldoon S.Testing for malignant hyperthermia.Anesthesiology,2002,96:232-237.
